Search results
Piper Sandler Lowers Leggett & Platt (NYSE:LEG) Price Target to $13.00
ETF DAILY NEWS· 4 days agoLeggett & Platt (NYSE:LEG – Get Free Report) had its price objective reduced by analysts at Piper...
What Will It Take for the Fed to Lower Rates?
New York Times· 5 days agoStubbornly high inflation has scrambled the central bank’s outlook. Wall Street is now shifting focus to Friday’s jobs report for clues on its next move....
Easing Worries About Possible Rate Hike May Generate Buying Interest
RTT News· 5 days agoThe major U.S. index futures are currently pointing to a notably higher open on Thursday, with stocks likely to move to the upside as traders continue to digest yesterday's Federal Reserve announcement ...
California Public Employees Retirement System Has $9.74 Million Stock Position in Capri Holdings...
ETF DAILY NEWS· 4 days agoCalifornia Public Employees Retirement System lessened its holdings in Capri Holdings Limited (NYSE:CPRI – Free Report) by 6.9% during the fourth quarter, according to its most recent 13F filing ...
Nasdaq jumps as jobs report revives rate cut hopes, Apple soars By Proactive Investors
Investing.com· 4 days agoStocks rallied at midday led by Big Tech on the back of Apple Inc (NASDAQ:AAPL, ETR:APC)'s upbeat ...
Leggett & Platt (NYSE:LEG) PT Lowered to $13.00
ETF DAILY NEWS· 8 hours agoLeggett & Platt (NYSE:LEG – Free Report) had its target price decreased by Truist Financial from $16.00 to $13.00 in a report issued on Friday, Benzinga reports. Truist Financial currently has ...
The Cannabis Industry Hopes for New Highs
New York Times· 6 days agoThe Justice Department’s recommendation that restrictions on marijuana be lifted have revived expectations for a business that has waited years for such...
Steven Madden (NASDAQ:SHOO) Surprises With Q1 Sales
StockStory via Yahoo Finance· 6 days agoShoe and apparel company Steven Madden (NASDAQ:SHOO) reported Q1 CY2024 results beating Wall Street analysts' expectations, with revenue up 19.1% year on...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
NBC San Diego· 6 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Earnings call: Century Aluminum sees strong Q1 performance, plans growth
Investing.com· 5 days agoCentury Aluminum Company (NASDAQ: CENX ) has reported a solid operational performance in the first...
